Showing 4061-4070 of 8250 results for "".
Cyclosporine Still Matters
https://crstoday.com/topics/refractive-surgery/cyclosporine-still-matters/43673/Even as Restasis goes off-patent, cyclosporine A continues to be the subject of innovative developments in ophthalmology.Secondary IOL Fixation
https://crstoday.com/crst-issues/may-2026/secondary-iol-fixation/60826/How we match the technique to the eye.Astigmatism Management During Cataract Surgery
https://crstoday.com/crst-issues/mar-2026/astigmatism-management-during-cataract-surgery/56587/Studies analyzed both the correction of low preoperative corneal cylinder and the management of astigmatism in highly myopic eyes.The Evil Magnet
https://crstoday.com/crst-issues/oct-2024/the-evil-magnet/45394/Four cases in which IOLs behaved like magnets inside the eye by attracting deposits that might affect the patients’ vision.Customized Toric IOLs as a Strategy to Build a Practice
https://crstoday.com/crst-issues/july-2023/customized-toric-iols-as-a-strategy-to-build-a-practice/45072/It can be one road to success in a highly competitive market.The Future of Electronic Health Records
https://crstoday.com/crst-issues/june-2023/the-future-of-electronic-health-records/45045/Increased involvement from software giants could alter health care.Detecting Systemic Vascular Disorders With AI
https://crstoday.com/crst-issues/june-2023/detecting-systemic-vascular-disorders-with-ai/45041/Automated interpretation of fundus photographs with AI-based systems shows promise.Social Media Use Among Ophthalmologists
https://crstoday.com/crst-issues/may-2023/social-media-use-among-ophthalmologists/45000/AI and Cataracts
https://crstoday.com/crst-issues/apr-2023/ai-and-cataracts/44980/Enhancing detection and surgical training.Controlling Postoperative Inflammation and Associated Complications With OMIDRIA
https://crstoday.com/crst-supplements/controlling-postoperative-inflammation-and-associated-complications-with-omidria/controlling-postoperative-inflammation-and-associated-complications-with-omidria-2/44776/The benefits of continuous intracameral administration of phenylephrine and ketorolac intraocular solution 1% / 0.3%.
